Zhang Xu, Cheng Mei, Chintala Shravan K
Eye Research Institute, Oakland University, Rochester, Michigan 48309, USA.
Invest Ophthalmol Vis Sci. 2004 Jul;45(7):2374-83. doi: 10.1167/iovs.03-1239.
Excitotoxicity has been proposed to play a pivotal role in retinal damage, but the mechanisms that underlie retinal damage are not clearly understood. In this study, the role of matrix metalloproteinases in excitotoxin-mediated retinal damage was investigated.
KA, CNQX (6-cyano-7-nitroquinoxaline-2,3,-dione), NBQX (2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline), MK801, or PBS was injected into the vitreous of CD-1 mice. MMP expression in the retina was analyzed by zymography, Western blot, and immunohistochemistry. Retinal ganglion cells (RGCs) were retrogradely labeled with aminostilbamidine methanesulfonate (Molecular Probes, Eugene, OR), and loss of fluorescently labeled RGCs in retinal flatmounts was quantified. Apoptotic cell death was assessed by TUNEL staining. Astrocyte activation was determined by immunohistochemistry, and laminin decrease was determined by immunohistochemistry and Western blot analysis.
Intravitreal injection of KA caused time- and dose-related MMP-9 upregulation in the retina. Increased MMP-9 activity and protein levels were associated with activation of astrocytes. Astrocyte-associated MMP-9 correlated with a decrease in laminin immunoreactivity in the ganglion cell layer and significant loss of retinal ganglion cells. KA-mediated upregulation of MMP-9 activity was associated with apoptosis of cells in the ganglion cell layer as early as 6 hours after injection, followed by apoptosis in cells in the inner nuclear layer by day 1. Intravitreal injection of the non-NMDA receptor antagonists, CNQX and NBQX decreased KA-induced MMP-9 activity and protein levels in the retina and attenuated retinal degeneration, whereas the NMDA receptor antagonist MK801 failed to offer protection. Further, a synthetic MMP inhibitor GM6001 decreased KA-mediated MMP-9 activity and offered significant protection against ganglion cell loss in the retina.
These results indicate that KA-mediated upregulation of MMP-9 activity promotes retinal degeneration and suggest that inhibition of KA-mediated MMP activity may offer protection against excitotoxin-induced retinal damage.
兴奋性毒性被认为在视网膜损伤中起关键作用,但视网膜损伤的潜在机制尚不清楚。在本研究中,我们调查了基质金属蛋白酶在兴奋性毒素介导的视网膜损伤中的作用。
将KA、CNQX(6-氰基-7-硝基喹喔啉-2,3-二酮)、NBQX(2,3-二羟基-6-硝基-7-氨磺酰基-苯并(F)喹喔啉)、MK801或PBS注射到CD-1小鼠的玻璃体中。通过酶谱分析、蛋白质印迹法和免疫组织化学分析视网膜中基质金属蛋白酶的表达。用甲磺酸氨基二苯乙烯脒(Molecular Probes,俄勒冈州尤金市)对视网膜神经节细胞(RGCs)进行逆行标记,并对视网膜平铺片中荧光标记的RGCs的损失进行定量。通过TUNEL染色评估凋亡细胞死亡。通过免疫组织化学确定星形胶质细胞活化,通过免疫组织化学和蛋白质印迹分析确定层粘连蛋白减少。
玻璃体内注射KA导致视网膜中MMP-9表达呈时间和剂量依赖性上调。MMP-9活性和蛋白水平的增加与星形胶质细胞的活化有关。与星形胶质细胞相关的MMP-9与神经节细胞层中层粘连蛋白免疫反应性的降低以及视网膜神经节细胞的显著损失相关。KA介导的MMP-9活性上调与注射后6小时神经节细胞层中的细胞凋亡相关,随后在第1天内核层中的细胞发生凋亡。玻璃体内注射非NMDA受体拮抗剂CNQX和NBQX可降低KA诱导的视网膜中MMP-9活性和蛋白水平,并减轻视网膜变性,而NMDA受体拮抗剂MK801未能提供保护作用。此外,一种合成的基质金属蛋白酶抑制剂GM6001可降低KA介导的MMP-9活性,并对视网膜神经节细胞损失提供显著保护。
这些结果表明,KA介导的MMP-9活性上调促进视网膜变性,并提示抑制KA介导的基质金属蛋白酶活性可能对兴奋性毒素诱导的视网膜损伤提供保护作用。